ANDREW MARTIN: Open Payments
NPI 1467474767 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $86 |
| Alkermes, Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: INGREZZA, ARISTADA, Sunosi, INVEGA SUSTENNA, HETLIOZ, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
